How is hemolytic uremic syndrome treated?
What does treatment for HUS commonly involve?Treatment of high blood pressure.Maintaining specific levels of fluids and salts.Blood transfusions.Kidney dialysis.Medicine.
How is shiga toxin treated?
There is no specific treatment for STEC infections. Since diarrhea can cause dehydration (loss of water in the body causing weakness or dizziness), drinking plenty of fluids to stay hydrated is important.
Do you treat HUS with antibiotics?
After adjustment for illness severity and gender, subjects who developed HUS were more likely to have been treated only with bactericidal antibiotics within the first 3 days (adjusted matched odds ratio [OR], 12.4; 95% confidence interval [CI], 1.4-110.3) or within the first 7 days (OR, 18.0; 95% CI, 1.9-170.9) after ...
How do you treat atypical HUS?
Supportive treatment of aHUS: Treatment includes blood transfusions, dialysis if indicated, and blood pressure control. Patients on dialysis may develop malignant hypertension, and bilateral nephrectomy may be needed to achieve blood pressure control in some of these patients.
Which of the following is the only option for the treatment of STEC?
Current treatment of STEC infections is solely supportive and includes rehydration therapy, and, where necessary, dialysis.
How does Shiga toxin cause HUS?
These strains are called Shiga toxin-producing E. coli, or STEC. When you are infected with a strain of STEC , the Shiga toxin can enter your bloodstream and cause damage to your blood vessels, which may lead to HUS .
Why are antibiotics not used in HUS?
Additionally, antibiotic-induced injury to the bacterial membrane favors the acute release of large amounts of toxins. Use of antibiotics has been shown to increase the risk of full-blown HUS by 17-fold, and thus, the recommendation is to avoid its use, except in cases of sepsis.
What antibiotic treats E coli?
Which medications in the drug class Antibiotics are used in the treatment of Escherichia coli (E coli) Infections?Antibiotics. ... Trimethoprim/sulfamethoxazole (Bactrim, Bactrim DS, Septra DS, Sulfatrim) ... Ciprofloxacin (Cipro) ... Levofloxacin (Levaquin) ... Amoxicillin (Moxatag) ... Aztreonam (Azactam)More items...
Why do antibiotics make E coli worse?
Antibiotics can worsen an E. Giving antibiotics, including fluoroquinolones such as Cipro, can kill a patient who has been sickened by any strain of Shiga toxin E. coli. The reason: when the bacteria die, they release the toxin in massive amounts.
Can aHUS be cured?
Atypical hemolytic uremic syndrome (aHUS) is a disease that causes blood clots in small blood vessels in your kidneys and other organs. These clots keep blood from getting to your kidneys, which can lead to serious medical problems, including kidney failure. There's no cure, but treatment can help manage the condition.
What kind of doctor treats aHUS?
Nephrologists should be key physicians in aHUS cases and should be heavily involved in treatment and care plans. Hematologists are experts in blood diseases. These doctors closely monitor aHUS activity and its effects on the patient's blood.
Can HUS go away on its own?
With proper care, patients with the disease can recover without permanent damage to their health. Antibiotics are not needed to treat diarrhea. The infection will resolve on its own. The use of antibiotics has in some studies been associated with an increased risk of developing HUS.
What antibiotics treat E. coli?
Which medications in the drug class Antibiotics are used in the treatment of Escherichia coli (E coli) Infections?Antibiotics. ... Trimethoprim/sulfamethoxazole (Bactrim, Bactrim DS, Septra DS, Sulfatrim) ... Ciprofloxacin (Cipro) ... Levofloxacin (Levaquin) ... Amoxicillin (Moxatag) ... Aztreonam (Azactam)More items...
How should a patient infected with STEC o26 be treated?
What is the best treatment for STEC infection? Non-specific supportive therapy, including hydration, is important. Antibiotics should not be used to treat this infection. There is no evidence that treatment with antibiotics is helpful, and taking antibiotics may increase the risk of HUS.
How is enterohemorrhagic E. coli treated?
EHEC is a foodborne disease that can be reduced by practicing good hygiene and controlling the contamination of food. It is a human pathogen found to be responsible for bloody diarrhea outbreaks and hemolytic uremic syndrome (HUS) worldwide. There is no specific treatment, but studies are being conducted.
How is E. coli 0157 treated?
There is no specific treatment for E. coli O157 infection. People who are infected can usually be cared for at home and most will get better without medical treatment. It is important to drink plenty of fluids, as diarrhoea can lead to dehydration.
What is the hemolytic uremic syndrome?
The hemolytic uremic syndrome (HUS) is defined by the simultaneous occurrence of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury [ 1 ]. The most common cause of HUS is due to Shiga toxin-producing Escherichia coli (STEC), and it is one of the main causes of acute kidney injury in children under the age of three years.
Is UpToDate a substitute for medical advice?
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of UpToDate content is governed by the UpToDate Terms of Use. ©2021 UpToDate, Inc. All rights reserved.
Is HUS atypical or atypical?
All other causes of HUS were referred to as atypical HUS or assigned to the diarrhea-negative HUS, even though some patients with non-STEC-associated HUS also presented with diarrhea.
What is a HUS?
Haemolytic uraemic syndrome (HUS) remains a leading cause of paediatric acute kidney injury (AKI). Haemolytic uraemic syndrome is characterised by the triad of microangiopathic haemolytic anaemia, thrombocytopenia and AKI. In ~ 90% of cases, HUS is a consequence of infection with Shiga toxin-producing E. coli (STEC), most commonly serotype O157:H7. Acute mortality from STEC-HUS is now less than 5%; however, there is significant long-term renal morbidity in one third of survivors. Currently, no specific treatment exists for STEC-HUS. There is growing interest in the role of complement in the pathogenesis of STEC-HUS due to the discovery of inherited and acquired dysregulation of the alternative complement system in the closely related disorder, atypical HUS (aHUS). The treatment of aHUS has been revolutionised by the introduction of the anti-C5 monoclonal antibody, eculizumab. However, the role of complement and anti-complement therapy in STEC-HUS remains unclear. Herein, we review the current evidence of the role of complement in STEC-HUS focusing on the use of eculizumab in this disease.
What is eculizumab used for?
Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
What is hemolytic uremic syndrome?
Hemolytic uremic syndrome (HUS) is a clinical syndrome comprising the triad of thrombocytopenia, thrombotic microangiopathy, and hemolytic anemia, and is frequently associated with acute kidney injury. Pathogenic challenge that results in endothelial injury or dysfunction shifts the hemostatic balance toward a pro-thrombotic environment, resulting in thrombotic microangiopathy with inappropriate deposition of clots in microvascular beds causing tissue ischemia. The kidney is a particular target during EHEC infection in part because the toxin receptors are expressed at higher density on glomerular endothelial cells [26] and toxin activities induce endothelial expression of adhesion molecules that support interactions with activated platelets and leukocytes [27] which contribute significantly to clot formation [28].
What are Shiga-like toxins?
It is widely acknowledged that the Shiga-like toxins produced by the enterohemorrhagic E. coliare the main virulence factors driving the organ damage in patients and animal models. EHEC secrete Shiga-like toxin-1 (Stx1) and/or Shiga-like toxin 2 (Stx2), and there are multiple Stx2 variants [36]. The two major toxins are structurally similar with a shared AB5domain structure, but only 56% amino acid homology. Stx are ribosome-inactivating toxins, similar to Shiga toxin from Shigella dysenteriaeserotype-1 [37] and ricin from castor beans. The enzymatic A subunit and a cell binding B subunit that organizes into pentamers recognize a globotriaosylceramide (Gb3) membrane receptor on cells, particularly glomerular endothelial cells [38]. Internalized toxin-receptor complexes undergo retrograde transport to the endoplasmic reticulum via the Golgi apparatus where the A subunit N-glycosidase activity removes an adenine from 28S ribosomal RNA to inhibit protein synthesis [39]. A recent study shows Stx1 intracellular trafficking is mediated by Golgi protein GPP130 and disruption of this interaction leads to lysosomal degradation of Stx1 and protection of mice from lethal toxemia [40]. The toxins also induce inflammation in patients [41] and animal models [42], and endoplasmic reticulum stress-induced transcriptional events are stimulated in susceptible cells [43,44].
What are the molecular pathways of thrombotic microangiopathy?
Thrombotic Microangiopathy can result from different molecular pathways. Hemolytic uremic syndrome (HUS), atypical HUS (aHUS) and thrombotic thrombocytopenic purpura (TTP) have shared clinical manifestations, but differing molecular etiologies. EHEC-related HUS initiated by bacterial Stx injures endothelial cells by inducing endoplasmic reticulum (ER) stress responses and transcription events which include generation of inflammatory cytokines and chemokines. Endothelial injury and a pro-thrombotic environment in aHUS results from genetic mutations in complement pathway members and aberrant activation (complement factors H, IB, 3: CFH, CFI, CFB, C3). Coagulopathy during TTP results from inherited or immune-acquired deficiency in a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13), needed to cleave vonWillebrand Factor (VWF) released from endothelial cells to prevent accumulation of prothrombotic ultra-large VWF (UL-VWF) oligomers.
What is a HUS?
Hemolytic uremic syndrome (HUS) is a serious clinical complication of EHEC infection and the severity of a public outbreak is often discussed in terms of the HUS rate. HUS is a clinical composite of thrombocytopenia, hemolytic anemia and thrombotic microangiopathy that contributes to acute kidney injury, often requiring dialysis and can progress to acute renal failure and death. Epidemiology studies have shown that HUS typically develops in about 5%–15% of patients, but this varies between bacterial strains and geographic location. Treatment is supportive, no toxin-specific therapies are available and antibiotics are usually contraindicated, depending on serotype. Recently, a large multi-state prospective study of 259 US children with HUS as a complication of EHEC O157:H7 infection demonstrated unequivocally that exposure to antibiotics of any class in the first week of illness was independently associated with development of HUS and tripled the risk [18]. For the O157:H7 strain, antibiotics increase toxin production due to location of stxgenes within antibiotic-inducible resident lambdoid prophages [19]. The recent outbreak in Germany with the Stx2-producing O104:H4 strain was notable for its high HUS rate at 22%, occurring overwhelmingly in adults (88%) and most of these being young women [12,15,20]. In this outbreak, use of antibiotics at one hospital center was beneficial, significantly reducing intestinal bacterial colonization duration and improving clinical outcome [21]. Unlike the more common O157:H7 strain, antibiotics reduced Stx secretion from this strain in vitro[22]. Argentina has the dubious distinction of having the highest incidence of pediatric diarrhea-associated HUS (13.9/100,000 population) and ~20% of Argentina’s pediatric kidney transplants are the result of EHEC infections [23]. Relative to other infectious disease outbreaks, the death rate from EHEC infection is fairly low at around 3%–5%, but morbidity associated with kidney injury is significant. About 12% of patients with diarrhea-associated HUS progress to end stage renal failure within 4 years and about 25% have long term renal impairment [24,25], putting them at high risk for other clinical complications as eventually encounter pregnancy, high blood pressure, diabetes, cardiovascular disease and other complications of aging.
What animal model was used to study enteric infections?
One of the earliest animal models of EHEC-mediated HUS was the gnotobiotic piglet. This animal had previously been used to study other human enteric infections [115]. Piglets were infected with ~1 × 1010CFU E. coli O157:H7 twenty-four hours after delivery and were euthanized and necropsied on either day three or day five. Ulcers and mononuclear cell infiltration were observed in the cecums of the animals euthanized on day five. Only minor focal lesions associated with bacterial antigen were observed in the kidney, and no hematological symptoms of hemolytic uremic syndrome were described [116].
When was the first EHEC outbreak?
Though the first recorded US outbreak of enterohemorrhagic Escherichia coli occurred in 1982 , a complete picture of how EHEC elicits disease in humans remains to be elucidated. EHEC infections are typically unpredictable common source outbreaks, so there are no endemic patient populations for systemic study of disease pathogenesis. The development of animal models has thus been necessary in order to study toxin-specific mechanisms that govern the observed disease process in humans. Animals may receive purified toxin(s) or bacteria, but despite the numerous animal models tried, none of them completely replicate the EHEC infection and HUS observed in patients. However, they do fulfill an important role in that they allow for the investigation of one or more aspects of pathogenesis of EHEC disease and HUS [102]. A brief summary of animal model features and limitations are shown in Table 1with representative references.
How many patients have hus?
Epidemiology studies have shown that HUS typically develops in about 5%–15% of patients, but this varies between bacterial strains and geographic location. Treatment is supportive, no toxin-specific therapies are available and antibiotics are usually contraindicated, depending on serotype.
Overview
- Hemolytic uremic syndrome (HUS) is a condition that can occur when the small blood vessels in your kidneys become damaged and inflamed. This damage can cause clots to form in the vessels. The clots clog the filtering system in the kidneys and lead to kidney failure, which could be life-threatening.Anyone can develop HUS, but it is most common in young children. In many c…
Prevention
- Meat or produce contaminated with E. coli won't necessarily look, feel or smell bad. To protect against E. coli infection and other foodborne illnesses: 1. Avoid unpasteurized milk, juice and cider. 2. Wash hands well before eating and after using the restroom and changing diapers. 3. Clean utensils and food surfaces often. 4. Cook meat to an internal temperature of at least 160 …
- 1. The organism is very common in cattle and a low level of infection causes clinical disease. Prevention is based on reducing faecal contamination during slaughtering and processing. 2. Good personal hygiene measures - eg, hand-washing before and after food-handling and eating, after toilet use and after contact with farm animals. 3. Increased public awareness about good f…
- Once HUS develops, there is no known treatment that can stop the progress of the syndrome. Unfortunately, it must run its course. Most treatments are supportive in nature and aimed at easing the immediate symptoms and signs of this disease and at preventing further complications. Supportive therapy consists of maintaining specific levels of fluids and salts, whi…
Causes
- The most common cause of HUS — particularly in children under the age of 5 — is infection with certain strains of E. coli bacteria. E. coli refers to a group of bacteria normally found in the intestines of healthy humans and animals. Most of the hundreds of types of E. coli are normal and harmless. But some strains of E. coli cause diarrhea.Some of the E.coli strains that cause diarrh…
- Yes. HUS is considered a syndrome because it is a combination of findings that may have different causes. In most cases, HUS occurs after a severe bowel infection with certain toxic strains of the bacteria called E. coli. It may also occur in response to certain medicines, but this is rare. Even more rarely, HUS occurs for unknown reasons. This fact sheet primarily focuses on th…
Signs And Symptoms
- The signs and symptoms of HUS may vary, depending on the cause. Most cases of HUS are caused by infection with certain strains of E. coli bacteria, which first affect the digestive tract. The initial signs and symptoms of this form of HUS may include: 1. Diarrhea, which is often bloody 2. Abdominal pain, cramping or bloating 3. Vomiting 4. FeverAll forms of HUS — no matter the c…
- HUS generally occurs in children who have had an illness involving diarrhea (usually bloody). Most children fully recover from their bowel illness without developing HUS. However, a small percentage will become pale and have less energy, due to the progression to HUS. Their urine output may also decrease, but a loss of color in the skin is the most striking symptom.
- The first stages of HUS frequently present with gastrointestinal symptoms such as abdominal pain, vomiting, and bloody diarrhea. This stage lasts from 1 to 15 days. Recovery from this acute colitic phase is the rule. However, more severe problems in the bowel and colon may develop in some cases. (The 5-10% most vulnerable and severely stricken of children with HUS can die duri…
Complications
- HUS can cause life-threatening complications, including: 1. Kidney failure, which can be sudden (acute) or develop over time (chronic) 2. High blood pressure 3. Stroke or seizures 4. Coma 5. Clotting problems, which can lead to bleeding 6. Heart problems 7. Digestive tract problems, such as problems with the intestines, gallbladder or pancreas...
- 1. Gastrointestinal: 1. Intestinal strictures and perforations. 2. Intussusception and rectal prolapse. 3. Pancreatitis. 4. Severe colitis. 2. Neurological: 1. Altered mental state. 2. Cerebrovascular accident (CVA). 3. Seizures. 3. Renal: 1. Acute kidney injury. 2. Chronic kidney disease. 3. Haematuria. 4. Hypertension. 5. Proteinuria.
Prognosis
- More than 85 percent of patients with the most common form of HUS recover complete kidney function. However, even with full recovery, there is the chance for high blood pressure or other kidney problems in the years ahead. In general, the outlook in HUS is related to the severity of involvement of other organs such as the brain, pancreas, liver or heart.
- 1. Typical HUS with a diarrhoeal prodrome usually has a good prognosis. The two British Paediatric Surveillance Unit prospective surveys in the UK and Ireland (1985-1988 and 1997-2001) of HUS in children aged under 16 years reported a mortality rate of HUS in the first of these surveys to be 5.6% and this had decreased to 1.8% in the second survey. 2. Death due to HUS is …
Risk Factors
- The majority of HUS cases are caused by infection with certain strains of E. coli bacteria. Exposure to E. coli can occur when you: 1. Eat contaminated meat or produce 2. Swim in pools or lakes contaminated with feces 3. Have close contact with an infected person, such as within a family or at a child care center.The risk of developing HUS is highest for: 1. Children 5 years of a…
Diagnosis
- Includes: 1. Other causes of abdominal pain and diarrhoea - eg, acute gastroenteritis, appendicitis, inflammatory bowel disease, intussusception. 2. DIC, perhaps with sepsis. 3. HELLP syndrome (= Haemolysis, Elevated Liver enzymes, Low Platelet count). 4. An autosomal dominant form of HUS exists with abnormality of the ADAMTS13 gene which encodes the von Willebrand factor. It tend…
- To confirm a diagnosis of HUS, your doctor is likely to perform a physical exam and recommend lab tests, including: 1. Blood tests. These tests can determine if your red blood cells are damaged. Blood tests can also reveal a low platelet count, low red blood cell count or a higher than normal level of creatinine, a waste product normally removed by your kidneys. 2. Urine test. This test ca…
Treatment
- HUS is generally treated with medical care in the hospital. Close attention to fluid volume is very important. This potentially includes intravenous (IV) fluids and nutritional supplementation by IV or tube feeding. A transfusion of blood may also be needed. In about 50 percent of cases, short-term kidney replacement treatment in the form of dialysis is necessary. Most patients who need …
- HUS requires treatment in the hospital. Lost fluids and electrolytes must be carefully replaced because the kidneys aren't removing fluids and waste as efficiently as normal.
Results
- We studied 27 adults with TTP-HUS and 51 control subjects with DIC. Three patients originally listed as having DIC had an alternative diagnosis on chart review and were excluded. Of the patients with TTP-HUS, 19 had idiopathic disease, 3 patients were postpartum, 2 patients had systemic lupus erythematosus, 1 patient was taking clopidogrel, 1 had a history of breast cancer…